During the past decade, Northern New Jersey Eye Institute conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northern New Jersey Eye Institute" #1 sponsor was "Allergan" with 2 trials, followed by "Glaukos Corporation" with 2 trials sponsored, "Santen Inc." with 2 trials sponsored, "Shire" with 2 trials sponsored and "Johnson & Johnson Surgical Vision, Inc." with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Northern New Jersey Eye Institute" are "Ocular Hypertension" (2 trials), "Adenoviral Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials), "Cataract" (1 trials) and "Corneal Astigmatism" (1 trials). Many other conditions were trialed in "Northern New Jersey Eye Institute" in a lesser frequency.

Most popular intervention types in "Northern New Jersey Eye Institute" are "Drug" (7 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "PVP-I 0.6%" (2 trials), "Placebo" (2 trials), "SHP640" (2 trials), "AGN-195263 0.01%" (1 trials) and "AGN-195263 0.03%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northern New Jersey Eye Institute" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Northern New Jersey Eye Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Northern New Jersey Eye Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Northern New Jersey Eye Institute, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".